Session 4: mCRPC: Which Treatment Option Would You Pursue? Session 4: mCRPC: Which Treatment Option Would You Pursue?

Session 4 focuses on mCRPC management including discussions on chemotherapy, radionuclides, and PARP inhibitors.Medscape Medical Affairs

Source: Medscape Today Headlines - October 13, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news